This brief illustrates the value of PreP, it’s use and outcomes, and EGPAF’s stance on implementation of PreP.
Explore Related Resources
Poster
Twenty-Four-Month Survival Among Patients with Cryptococcal Antigenemia Enrolled in Malawi’s Advanced HIV Disease Program: A Retrospective Cohort Study
Published August 2026
We assessed 24-month survival and factors associated with mortality among AHD clients with cryptococcal antigenemia enrolled in Malawi’s AHD program.
Topics:
Advanced HIV Disease (AHD)
Countries:
Malawi
Poster
From Mortality Review to Mortality Reduction: The Importance of Embedding Routine Pediatric HIV Death Audits in Tanzania
Published August 2026
We assessed the implementation of standardized pediatric mortality audits and associated programmatic responses on mortality trends among CLHIV in Tanzania.
Topics:
Pediatric HIV,
Research
Countries:
Tanzania
Issue Briefs
Common Ground for Global Health Policy Brief: Pediatric HIV
Published June 2026
Overview Children* are disproportionately affected by the HIV epidemic yet are consistently deprioritized and underserved compared to other affected populations. UNAIDS’ global treatment targets call for 95% of people living with HIV to know their status; 95% of people who know their status to be on treatment; and 95% of people on treatment to sustain […]
Topics:
Advocacy,
Pediatric HIV
Countries:
Global